Drug Shortage Report for APO-RANITIDINE TABLET 300MG

Last updated on 2017-07-22 History
Report ID 8889
Drug Identification Number 00733067
Brand name APO-RANITIDINE TABLET 300MG
Common or Proper name RANITIDINE
Company Name APOTEX INC
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-06-12
Actual start date 2017-05-15
Estimated end date 2017-08-08
Actual end date 2017-07-21
Shortage status Resolved
Updated date 2017-07-22
Company comments APO-RANITIDINE FCT 300MG 500 BTL available
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-07-22 French Compare
v7 2017-07-22 English Compare
v6 2017-07-17 French Compare
v5 2017-07-17 English Compare
v4 2017-05-16 French Compare
v3 2017-05-16 English Compare
v2 2017-05-04 French Compare
v1 2017-05-04 English Compare